Hester Biosciences Ltd.
Snapshot View

1782.95 -5.40 ▼-0.3%

02 February 2023, 04:01:00 PM
Volume: 140

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.hester.in
Market Cap 1,527.07 Cr.
Enterprise Value(EV) 1,769.96 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 35.05 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 50.86 Trailing Twelve Months Ending 2022-12
Industry PE 32.44 Trailing Twelve Months Ending 2022-12
Book Value / Share 322.40 Trailing Twelve Months Ending 2022-12
Price to Book Value 5.53 Calculated using Price: 1,782.95
Dividend Yield 0.56 Period Ending 2022-03
No. of Shares Subscribed 0.85 Cr. 8,506,865 Shares
FaceValue 10
Company Profile
Hester Biosciences was incorporated on April 29, 1987 as a Private Limited Company by the name of Hester Pharmaceuticals Limited. It was subsequently converted into a Public Limited Company on November 1, 1993. The company is engaged in the manufacturing of poultry vaccines. The company has been promoted by Rajiv D. Gandhi his brother Sanjiv D. Gandhi and Dr. Bhupendra V. Gandhi. The company changed its name to the present in 2008.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-0.30%
1 Week
-0.83%
1 Month
-0.77%
3 Month
-10.47%
6 Month
-21.80%
1 Year
-28.39%
2 Year
+2.36%
5 Year
+17.07%
10 Year
+1293.47%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 12.88 16.73 20.56 20.38 17.57 25.59 16.38 16.16 16.00
Return on Capital Employed (%) 17.78 17.26 18.98 19.75 20.20 26.64 16.53 17.33 14.02
Return on Assets (%) 6.89 8.84 11.08 11.43 10.10 14.97 9.04 8.70 8.03

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 75 85 102 122 141 177 201 228 260 264
Non Curr. Liab. 20 38 41 48 44 70 97 114 198 244
Curr. Liab. 45 35 38 38 55 49 83 61 97 109
Minority Int. 1 3 5 5 4 4 5 8 7 7
Equity & Liab. 142 160 186 213 244 299 387 411 562 624
Non Curr. Assets 85 100 112 133 146 158 227 250 367 418
Curr. Assets 57 60 74 80 98 142 159 162 195 206
Misc. Exp. not W/O
Total Assets 142 160 186 213 244 299 387 411 562 624

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 69 90 101 123 136 178 183 214 235 255
Other Income 1 0 1 0 3 7 6 5 14 19
Total Income 70 90 102 124 138 185 190 219 249 274
Total Expenditure -45 -65 -68 -82 -89 -110 -128 -146 -175 -206
PBIDT 25 26 34 41 50 75 62 73 74 68
Interest -6 -5 -4 -4 -4 -7 -7 -7 -4 -9
Depreciation -5 -6 -6 -7 -10 -12 -13 -13 -17 -20
Taxation -4 -5 -6 -8 -13 -16 -10 -15 -14 -12
Exceptional Items 3 -3
PAT 9 13 19 23 23 41 31 35 39 27
Minority Interest 0 0 0 1 3 1 -2 0 0 -2
Share Associate 0 5
Other Related Items
Consolidated Net Profit 9 14 19 24 26 42 29 34 39 30
Adjusted EPS 11 16 23 28 30 49 34 40 46 35

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 12 9 20 19 35 38 47 37 58 9
Cash Fr. Inv. -23 -15 -21 -13 -30 -26 -22 -74 -38 -117
Cash Fr. Finan. 10 7 7 -7 2 -11 3 19 -18 112
Net Change -1 2 5 -1 6 1 28 -19 1 4
Cash & Cash Eqvt 2 4 6 5 11 12 41 24 21 25

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 53.73 53.73 53.73 53.73 53.73 53.73 53.73 53.73 53.73
Public 46.27 46.27 46.27 46.27 46.27 46.27 46.27 46.27 46.27
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 02 Feb 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulations 30 and 46(2)(oa) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find attached the transcript of the earnings conference call held by the management of the Company with investors on Tuesday 31 January 2023 at 2:00 p.m. (IST) to discuss the unaudited financial results for the quarter and nine months ended 31 December 2022. This is for your information and records.
Wed, 01 Feb 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby submit a copy of the published extract of consolidated unaudited financial results for the quarter and nine months ended 31 December 2022 along with information on standalone financial results.The same was published on Wednesday 1 February 2023 in the Ahmedabad edition of Financial Express (English) and Financial Express (Gujarati).
Tue, 31 Jan 2023
Financial Results For Q3 & 9M FY23
Financial Results for Q3 & 9M FY23

Technical Scans View Details >>

Thu, 02 Feb 2023
High Delivery Percentage High Delivery Percentage
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease in 6 Months High Decrease in 6 Months
Closing Near 20 SMA Closing Near 20 SMA
Close Crossing 20 SMA From Below Close Crossing 20 SMA From Below

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 241,852.96 1,008.00 -0.6%
Divi's Laboratories Ltd. 86,732.57 3,271.90 -2.5%
Cipla Ltd. 82,728.22 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. 72,771.66 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. 60,864.05 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. 52,144.29 1,541.15 +0.5%
Zydus Lifesciences Ltd. 43,787.95 432.60 -0.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 57.42 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-09 29.03 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-12 31.36 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.95 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.52 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.77 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-09 22.59 432.60 -0.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.37 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-09 7.16 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-12 3.65 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.30 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.17 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.18 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-09 2.63 432.60 -0.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 432.60 -0.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 432.60 -0.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 432.60 -0.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 432.60 -0.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 432.60 -0.7%

FAQ's On Hester Biosciences Ltd.

What is Hester Biosciences share price?

Can I buy Hester Biosciences shares now?

What is the Dividend Yield of Hester Biosciences?

What is the Market Cap of Hester Biosciences?

What are the key metrics to analyse Hester Biosciences?

What is the 52 Week High and Low of Hester Biosciences?

What is the trend of Hester Biosciences share price?